Adjunct Senior Research Fellow, Institute for Molecular Bioscience
Affiliate Professor, Queensland Brain Institute, The University of Queensland
On May 12, 2021, Jake Gratten and Naomi Wray will present findings from the Australian Autism Biobank study, an initiative to establish an Australian resource of biospecimens, phenotypes and genomic data for autism research.
Small molecules, genes and antisense oligonucleotides: Industry perspectives on treatment development for ASD
Vice President, Head of Clinical Science, Axial Therapeutics
Stuart Cobb, Ph.D.
Chief Scientific Officer, Neurogene; Research Fellow, University of Edinburgh
Yael Weiss, M.D., Ph.D.
Vice President, Business Development, Ultragenyx
Randy Carpenter, M.D.
Chief Medical Officer, Rett Syndrome Research Trust; Co-Founder, Allos Pharma
On May 14, 2021, Federico Bolognani, Stuart Cobb, and Yael Weiss will join a panel to discuss new industry developments on the use of small molecules, gene therapy and antisense oligonucleotides as treatment approaches for autism spectrum disorders (ASD). The panel discussion will be moderated by Randall Carpenter.
On May 20, 2021, the SFARI science team will hold an informational session to answer questions about the 2021 Genomics of ASD: Pathways to Genetic Therapies request for applications.
Chief Clinical Officer, Dascena
Joseph Buxbaum, Ph.D.
Director, Seaver Autism Center
Professor, Psychiatry, Neuroscience, Genetics and Genomic Sciences
Vice Chair for Research and Vice Chair for Mentoring, Psychiatry, Icahn School of Medicine at Mount Sinai
Heather Mefford, M.D., Ph.D.
Full Member, St. Jude Children’s Research Hospital
On May 21, 2021, David Ledbetter and Joseph Buxbaum will discuss whether there are genes for which mutations confer risk specific to autism or whether these genes are really conferring general risk of disrupted brain development. The discussion will be moderated by Heather Mefford.
On March 24, 2021, SFARI held an informational session to answer questions about the 2021 Human Cognitive and Behavioral Science request for applications.
Elizabeth Berry-Kravis discussed refinements in clinical trial design and outcome measures that contributed to the success of a recent phase II trial for fragile X syndrome.
On January 26, 2021, SFARI will host a Twitter chat Q&A on the Bridge to Independence (BTI) Award program and the 2021 BTI request for applications.
SFARI hosted a virtual social focused on the Bridge to Independence (BTI) Award, in conjunction with the SfN Global Connectome: A Virtual Event on January 13, 2021.
SFARI hosted a virtual Social in conjunction with the SfN Global Connectome: A Virtual Event on January 11, 2021.
Evan Eichler discussed his research on the genetics of autism and related neurodevelopmental conditions.